Pharma channel feed – Endpoints News

Pharma channel feed

J&J discontinues mid-stage dengue study, citing deprioritization of communicable disease work

8 months ago

Sanofi sells rare disease drug Enjaymo to Recordati for $825M upfront

8 months ago

End of obesity drug shortage threatens patient access to compounded shots that Lilly calls risky

8 months ago

UK government proposes phased rollout of Eli Lilly's weight loss drug

8 months ago

Novo and Lilly outline plans to mitigate disruptions from US port strikes

8 months ago

Eli Lilly resolves shortage for tirzepatide, potentially ending compounders' run

8 months ago

For next round of IRA price negotiations, US says it will meet with companies sooner

8 months ago

AstraZeneca, AbbVie, PhRMA lose court battle over Louisiana 340B law

8 months ago

Gilead licenses HIV shot to six generic manufacturers, but falls short of access sought by advocates

8 months ago

J&J budgets over $2B for new North Carolina biologics facility

8 months ago

Lilly invests $4.5B in new Indiana site to bring clinical manufacturing in-house

8 months ago

GSK’s ViiV stops development of Phase 2 HIV antiviral

8 months ago

Judge keeps Amgen's $10.7B tax liability suit alive

8 months ago

J&J and Bayer to lay off almost 300 staffers in New Jersey

8 months ago

23andMe CEO says she is no longer open to outside takeover offers

8 months ago

Federal judge dismisses longstanding suit over Bristol Myers' $74B Celgene buyout

8 months ago

California's Gavin Newsom vetoes bipartisan PBM reform bill

8 months ago

J&J pulls the plug on 340B rebate model changes opposed by government

8 months ago

Updated: Pfizer to further decrease stake in consumer health company Haleon

8 months ago

Lilly-partnered radiopharma startup Aktis Oncology raises $175M

8 months ago

For some multiple myeloma patients, Carvykti cut risk of death by 45%

8 months ago

US government renews threats over J&J's proposed 340B rebate model

8 months ago

Novo Nordisk to decrease some insulin pen manufacturing, transition supply

8 months ago

FDA approves Dupixent in COPD, opening ‘next chapter’ for Sanofi and Regeneron’s bestseller

8 months ago

First page Previous page 33 34 353637 38 39 Next page Last page